Radiation: Computed tomography lung subtraction iodine mapping ( DrugBank: Iodine )
1 disease
| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 88 | Chronic thromboembolic pulmonary hypertension | 1 |
88. Chronic thromboembolic pulmonary hypertension
Clinical trials : 159 / Drugs : 118 - (DrugBank : 23) / Drug target genes : 13 - Drug target pathways : 53
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT03806907 (ClinicalTrials.gov) | April 1, 2019 | 15/1/2019 | Iodine Subtraction Mapping in the Diagnosis of Chronic Pulmonary Thromboembolic Disease | IodiNe Subtraction maPpIng in the Diagnosis of chRonic Pulmonary thromboEmbolic Disease (INSPIRE): An Observational Diagnostic Study | Chronic Thromboembolic Pulmonary Hypertension | Radiation: Computed tomography lung subtraction iodine mapping | University of Sheffield | Sheffield Teaching Hospitals NHS Foundation Trust | Not yet recruiting | 18 Years | 90 Years | All | 100 | NULL |